The expressions of some terminal glycotopes of synovial immunoglobulins G, A, and M were analysed in relation to rheumatoid arthritis (RA) progression deWned according to early and advanced radiological changes in patients' hands. The relative amounts of terminal monosaccharides were determined by lectin-immunoblotting of immunoglobulin preparations using appropriate lectins able to recognize 2,6-linked (Sambucus nigra agglutinin) and 2,3-linked (Maackia amurensis agglutinin) sialic acid, galactose (Ricinus communis agglutinin I), N-acetylglucosamine (GriVonia simplicifolia agglutinin II) as well as 1,6-linked (Aleuria aurantia lectin), 1,3-linked (Lotus tetragonolobus agglutinin), and 1,2-linked (Ulex europaeus agglutinin) fucose. The results indicate diVerences between early and advanced RA stages in the terminal sugar exposition of synovial IgG and IgA, but not IgM. The galactose-deWcient glycotope with exposed N-acetylglucosamine of the synovial 33.1-kDa IgG fragment appeared exclusively in the early stage of RA. In contrast, this glycotope of intact synovial IgG and IgA was present in both groups, although with higher proportions in advanced RA.
Introduction
Rheumatoid arthritis (RA) is a chronic autoimmune inXammatory and systemic disease which leads to joint inXammation and results in bone and cartilage erosion, tendon destruction, and joint dysfunctions and disabilities [1] . The aetiology of disease is not well deWned, but a bacterial or viral background as well as an autoimmunological theory in which the immune system is activated after reaction with an unknown antigen is considered. One of the most characteristic symptoms of RA is the production autoantibodies to citrullinated proteins and to the Fc region of IgG, deWned as rheumatoid factor (RF) (reviewed in [2] ).
Extensive studies have shown that the mechanisms of RA could be associated with changes in IgG glycosylation. The alterations in IgG proWle are conWned to changes in the level of terminal galactose and number of antennas as well as in the relative proportions of sialic acid, fucose, and bisecting GlcNAc (reviewed in [3] [4] [5] ). In RA, there is an increase in the number of oligosaccharide structures that lack the terminal galactose residue [3, 5] . GlycomodiWcations of IgG molecules have been shown to aVect various eVector functions (i.e. immune complex formation, activation of complement, and binding to monocytes) and to have a critical role in the regulation of the immune response [5] .
There is no single laboratory test available that helps to distinguish rheumatic diseases or the degree of RA progression, although certain serological tests seem to be associated with speciWc disease-related mechanisms. For the characterization of RA it is very important to distinguish between early and advanced RA stages and to determine progression and remission periods. Since the glycosylation of glycoproteins is sensitive to alterations in cellular function, changes in glycosylation can be used as a diagnostic value in a number of diseases, including rheumatoid arthritis [4] [5] [6] . A decreased level of glycan galactosylation in serum and synovial Xuid IgG is known to be associated with disease progression and is used as a prognostic indicator for RA. Patients with arthritis and high levels of hypogalactosylated IgG have poor prognosis [4] [5] [6] [7] . Finally, Pasek et al. [8] and Croce et al. [9] provided experimental evidence that the treatment of the RA patients with methotrexate or a combination of methotrexate and inXiximab also improves the degree galactosylation of serum IgG and, in their opinion, the analysis of IgG galactosylation in RA patients may have clinical relevance.
The aim of this study was to investigate whether the main classes of immunoglobulins undergo degradation in the synovial Xuid of RA patients in relation to rheumatoid arthritis progression deWned according to early and advanced radiological changes in the patients' hands. Moreover, semiquantitative alterations in the expressions of the terminal glycotopes of synovial IgG, IgA, and IgM were studied in relation to RA progression. The relative amounts of terminal monosaccharides were analysed by lectin-immunoblotting of salted-out immunoglobulins using appropriate lectins able to recognize 2,6-linked (SNA: Sambucus nigra agglutinin) and 2,3-linked (MAA: Maackia amurensis agglutinin) sialic acid, galactose (RCA I: Ricinus communis agglutinin I), N-acetylglucosamine (GSL II: GriVonia simplicifolia agglutinin II) as well as 1,6-linked (AAL: Aleuria aurantia lectin), 1,3-linked (LTA: Lotus tetragonolobus agglutinin) and 1,2-linked (UEA: Ulex europaeus agglutinin) fucose. However, the data did not show the "true" glycan structures, but rather reXected the exposition of the conformationally accessible terminal monosaccharides of synovial immunoglobulins.
Materials and methods

Patients and samples
In the present study, the synovial samples were from 38 patients (22-72 years old, mean age 49 § 12 years) who were attending the Rheumatology Clinic of Wrociaw Medical University. The patients fulWlled the American Rheumatism Association criteria for RA [10] and they gave their informed consent. The patients were evaluated on the basis of a clinical examination, plain X-rays of the hands, and standard laboratory blood plasma parameters, including CRP determination as an indicator of disease activity. The duration of RA was from 2 months to 15 years. Patients who had isotopic synovectomy, previous joint surgery, or traumatic, septic, or microcrystalline arthritis within the 12 months before the study were excluded. The normal blood plasma samples (26 healthy volunteers; 37-79 years old; mean age 54 § 15 years) were positive controls for analysis of the synovial immunoglobulin reactivities with lectins. The study was approved by the local ethics committee (approval no. 501/2006). Synovial Xuid and normal blood plasma were collected into plastic syringes and placed directly into tubes containing 1 mM phenylmethylsulfonyl Xuoride (PMSF, Sigma Chemical Co., St. Louis, MO, USA). The samples were centrifuged and the supernatants were stored in small aliquots at ¡78°C until used.
The patients' synovial samples were divided into two RA groups with respect to the radiographic outcome by scoring the X-rays of their hands [11] . The Wrst was the early RA group (15 samples). The patients had early radiological changes, described as soft-tissue swelling symmetrically around the involved joints, subtle juxtaarticular osteoporosis, and small erosions of the "bare" areas of bone. All the patients had suVered from 2 months to 2 years, 47% were RF positive, 60% had a C-reactive protein (CRP) concentration lower than 5 mg/l, and, as was shown previously [12] , Wbronectin was degraded to fragments reactive with the monoclonal antibody against the cellular domain of Wbronectin. The second group, with advanced RA, consisted of 23 patients with disease duration of from 2 months to 15 years and 83% of patients suVered more than 2 years. Fifty percent of the samples were RF positive and in 66% of the samples the CRP concentration was higher than 5 mg/l. They had established or late radiological RA changes. In most cases the patients had changes such as joint-space loss, decrease in soft-tissue swelling, large subchondral erosions, subluxation, diVuse osteoporosis, and Wbrous ankylosis of the digits. Forty-eight percent of the samples contained highmolecular Wbronectin and the rest partially degraded Wbronectin [12] .
Equal volumes of synovial and blood plasma samples were pooled in each group and the immunoglobulin fractions were precipitated with ammonium sulfate to 40% saturation. The pellets were centrifuged for 30 min at 4,000g and the precipitates were washed twice using cold 1.75 M ammonium sulfate. Then, the precipitates were dissolved in 100 l of water and the immunoglobulin concentration was measured by UV spectrophotometry and calculated using the molar absorption coeYcient of 0.7.
SDS-electrophoresis and Western blot
The solution containing 2 g of immunoglobulin preparation was denatured at 100°C for 5 min in the presence of 7.5% -mercapto-ethanol and subjected to SDS-PAGE in a 12.5% gel, according to Laemmli [13] . After electrophoresis, the separated samples were transferred onto nitrocellulose (Serva Electrophoresis GmbH, Heidelberg, Germany) according to Towbin et al. [14] for 1.5 h (120 mA) and then blocked with 3% milk in TBS, pH 7.5. The blotted immunoglobulins were analysed in the reaction with speciWc antibodies and biotinylated lectins.
The reactivity of immunoglobulins with speciWc antibodies
To identify the immunoglobulin band positions in the lectin-blotting pattern, Western immunoblotting was performed as previously described [15] . BrieXy, after the SDS-electrophoresis, protein transfer, and blocking steps, the respective blots were incubated with rabbit antihuman immunoglobulin M (IgM) (DAKO, Denmark; 2.5 g/ml), rabbit anti-human immunoglobulin A (IgA) (DAKO, Denmark; 1.64 g/ml), or the goat anti-human F(abЈ) 2 fragment of immunoglobulin G (IgG) (Jackson ImmunoResaearch Laboratories, USA; 1 g/ml) antibody. Then the blots were incubated with the respective antianimal immunoglobulins conjugated with horseradish peroxidase (Sigma, St. Louis, MO, USA) diluted 1:5,000 with 3% milk in TBS, pH 7.5. The colour reaction was developed with diaminobenzidine. The molecular masses of the antibody-reactive bands were estimated using a standard mixture of seven proteins with deWned molecular weights (Protein Test Mixture 6 for SDS PAGE; SERVA Electrophoresis, Germany): phosphorylase B (97.4 kDa), albumin bovine (BSA; 67 kDa), albumin egg (45 kDa), carbonic anhydrase (29 kDa), trypsin inhibitor (soybean; 21 kDa), cytochrome C (12.5 kDa), and trypsin inhibitor (bovine lung; 6.5 kDa).
The lectin-blotting of immunoglobulins
The reactivities of IgM, IgA, and IgG with lectins were analysed by Western blot using biotinylated lectins (Vector Laboratories Inc., Burlingame, USA). Sambucus nigra agglutinin [16] and Maackia amurensis agglutinin [17] are commonly used for 2,6-linked and 2,3-linked sialic acid determination, respectively. Ricinus communis agglutinin I [18] and GriVonia simplicifolia lectin II [19] are known to react with terminal galactose and N-acetylglucosamine residues, respectively. None of the fucose-speciWc lectins has an absolute speciWcity; however, Aleuria aurantia lectin [20] mainly reacts with the innermost 1,6-linked fucose to a core N-acetylglucosamine of N-glycans and with lower aYnity with 1,2-and 1,3-linked fucoses of the outer arms, whereas Lotus tetragonolobus agglutinin [21] and Ulex europaeus agglutinin [22] are known to recognize 1,3-linked and 1,2-linked fucoses to the galactose or N-acetylglucosamine of the antennas, respectively. However, the terminal 2,3-sialic acid limits the binding of LTA to 1,3-linked fucose of Lewis x structure [21] and the appearance of a 1,2-fucosylated structure reduces the attachment of 2,3-sialic acid to glycans [23] .
The lectin-blotting details are as follows: after the SDSelectrophoresis, transfer onto nitrocellulose, and blocking and washing steps, the respective blots were incubated at room temperature for 1 h with biotin-labelled lectins diluted with TBS containing 0.1% Tween 20, pH 7.5 (TBS-T), to the following Wnal concentrations: SNA 1 g/ml, MAA 5 g/ml, RCA I 0.5 g/ml, GSL II 1 g/ml, AAL 5 g/ml, LTA 10 g/ml, and UEA 10 g/ml. The formed lectin-immunoglobulin complex was detected by the reaction with phosphatase-labelled ExtrAvidin (Sigma, St. Louis, MO, USA) diluted 1:10,000 in TBS-T. The colour reaction was developed with nitro blue tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate (Sigma, St. Louis, MO, USA) diluted in TBS containing 0.05 M MgCl 2 ·6H 2 O, pH 9.5, and stopped by deionised water. The blots were dried, scanned, quantiWed, and analysed. The lectin-blotting was done with 3-6 repetitions for each synovial RA preparation. The immunoglobulin bands of the lectin reactivity were quantiWed by densitometric analysis using GelScan Software version 1.45 (Kucharczyk Electrophoretic Techniques, Poland). The relative content of a lectin-reactive immunoglobulin band was expressed as the percentage of the total number of pixels in a lane. Non-immunoglobulin proteins (not reactive with anti-IgM, anti-IgA, and anti-IgG antibodies) were not analysed. The speciWcity of the lectins was checked in the reaction with positive controls, i.e. transferrin for SNA (the Glycan DiVerentiation Kit, Boehringer Mannheim, Germany), mouse glycophorin for MAA (a gift from Prof. Hubert Krotkiewski, Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrociaw, Poland), and an asialo-haptoglobin preparation derived from ovarian cancer Xuid [24] for AAL, LTA, and UEA. A human albumin preparation (Sigma, St. Louis, MO, USA) was used as a negative control.
Results
The lectin-immunoblotting pattern of synovial Xuid (Fig. 1) using SNA, MAA, RCA I, GSL II, AAL, LTA, and UEA shows the bands terminated, respectively, by 2,6-and 2,3-linked sialic acids, galactose, N-acetylglucosamine, and 1,6-, 1,3-, and 1,2-linked fucoses expressed in the heavy chains of IgM ( = 88 kDa), IgA ( = 65.3 kDa), and IgG ( = 54.3 kDa) as well as in the 58-kDa IgA, 33.1-kDa IgG and 29.8-kDa IgG forms [15] and in the light chain of immunoglobulins (27.4 kDa) of patients with early and advanced stages of RA. Table 1 comprises the results of the percent participation of the lectin-reactive bands of the synovial immunoglobulins ( Fig. 1) in the early and advanced groups of RA.
The reactivity of synovial IgM with lectins
The relative content of the SNA-reactive bands of the chain (88 kDa) of IgM was similar in the early and advanced RA groups (13.3 and 13.2%, respectively), whereas the content of MAA-reactive bands was marginal in the early (2%) and advanced RA (0%) groups.
The RCA I-and AAL-reactive bands of IgM heavy chain were detected in both RA groups, and their proportions were slightly lower in the early RA group (8.6 and 10.6%, respectively) than in the advanced RA group (10.6 and 15.5%, respectively). In contrast, no reactivity of the -chain band with GSL II, LTA, or UEA was observed in either RA group (Table 1) .
The reactivity of synovial IgA with lectins
In the early RA group the proportions of the 65.3-kDa IgA heavy chain band reactive with SNA (27.5%), MAA (8.3%), RCA I (22.3%), AAL (11.6%), and LTA (14.3%) were slightly lower than in the advanced RA group (36.5, 13.1, 32.1, 19.7, and 18.5%, respectively) ( Table 1) . However, the proportions of the GSL II-and UEA-reactive 65.3-kDa IgA heavy chain band were signiWcantly lower in early RA (9.3 and 9.7%, respectively) than in the advanced RA (24.8 and 22.4%, respectively).
The relative content of the SNA-reactive 58-kDa IgA band was slightly lower in early RA than in the advanced RA (10.4 and 15.4%, respectively). In contrast, the relative content of 58-kDa IgA reactive with MAA was higher in early RA than in advanced RA (10.6 and 8.4%, respectively). Reactivity with RCA I, LTA, and UEA was observed in early RA only (11.8, 5.3, and 8.3%, respectively), but not in advanced RA. No reactivity of 58-kDa IgA was observed with GSL II or AAL in either RA group (Table 1) .
The reactivity of synovial IgG with lectins
In the early RA group, the relative content of 54.3-kDa IgG heavy chain reactive with SNA was slightly higher (24%) than in advanced RA (19.2%). In contrast, in the early RA preparation the proportions of IgG heavy chain reactive with MAA (34%), RCA I (27.2%), GSL II (50%), AAL (37.6%), LTA (24.2%), and UEA (31.6%) were lower than in the advanced RA group (MAA 45.6%, RCA I 40.7%, GSL II 61.5%, AAL 58%, LTA 32.6%, UEA 36.2%) ( Table 1) .
Reactivity of the 33.1-kDa IgG band with the used lectins was detectable in the early RA group only (SNA 7.7%, MAA 13.9%, RCA I 16.5%, GSL II 32.7%, AAL 32.8%, LTA 11%, and UEA 12.3%). This band was not recognized by the antibody and lectins in the advanced RA group (Table 1 ). The proportions of the SNA-and MAA-reactive 29.8-kDa IgG band were similar in the early and advanced RA groups (11.4 and 12.1% for SNA, and 4.5 and 2.6% for MAA, respectively). This band had no reactivity with RCA I or GSL II in either RA groups, but a slight reactivity with AAL in the advanced RA group (2.3%) was observed. In the early RA the proportions of 29.8-kDa IgG recognized by LTA (7.8%) and UEA (6.3%) were low, and even lower for LTA (2.5%), and it lost to bind UEA in advanced RA ( Table 1 ).
The reactivity of synovial light chain with lectins
The immunoglobulin light chain (27.4 kDa) showed reactivity with all tested lectins, but no signiWcant diVerences were found (Table 1) .
Discussion
The results indicate diVerences between early and advanced RA stages in the terminal sugar exposition of synovial immunoglobulin G and A, but not IgM. The galactose-deWcient glycotope with exposed N-acetylglucosamine of the synovial 33.1-kDa IgG fragment appeared exclusively in the early stage of RA. Moreover, the 33.1-kDa IgG fragment was also absent in normal blood plasma (Table 1) . In contrast, this glycotope of intact synovial IgG and IgA was present in both groups, although in higher relative amounts in advanced RA. Moreover, the relative amounts of the Table 1 The reactivity of synovial immunoglobulins with lectins in relation to RA progression
The early and advanced RA groups were determined according to radiographs of the patients' hands [11] . The reactivity with lectins of salted-out immunoglobulin preparations of the early and advanced RA synovial Xuid and normal plasma was performed by Western blotting using speciWc biotinylated lectins (see "Materials and methods"). sialyl and fucosyl determinants of intact A and G immunoglobulins were evidently lower in the synovial early RA and normal plasma groups than in the synovial advanced RA group. The alterations we observed in terminal monosaccharide expression between early and advanced RA probably resulted from diVerent molecular processes which are known to occur locally in joints during disease progression. In the early stage of RA, the synovium is inWltrated by highly activated immunological cells producing and transiently releasing proinXammatory agents which penetrate the cartilage, leading to a cascade of events promoting inXammation [1, 25, 26] . Various activated proteases and glycosidases may hydrolyze extracellular matrix components and soluble proteins, leading to the presence of fragmented proteins which, if they are glycoproteins, can appear in many glycoforms [27] .
Several studies have shown that proteolytic fragments may contribute greatly to the pathological state of RA [12, 28] . For example, the early stage of RA, but not the advanced disease, is accompanied by the presence of Wbronectin fragments [12] whose glycans were evidently desialylated and defucosylated [29] . With progression and stabilization of disease, profound metabolic changes have been described, for example, a decreasing cytokine proWle, an increase in proteoglycan synthesis, and enhanced anabolic factor release. With persistent inXammation, apart from the still active destructive processes, the enhanced anabolic reparative phase makes cartilage more refractory, leading to further erosive damage [1, 25] . The intensive degradation of proteins consequently comes to a stop and mainly intact molecules of FN, not degraded proteins, remain in synovial Xuid [12] .
The present study indicates that not only matrix proteins, but also synovial IgG undergoes sensitive degradation. As we previously reported [15] , two IgG fragments (33.1 and 29.8 kDa) immunoreactive with anti-IgG antibodies appeared in the synovial Xuid in signiWcant relative amounts ( Fig. 1; Table 1 ). One of them, with the molecular weight of 33.1 kDa, was exclusively associated with early RA. At the same time synovial IgA and IgM polypeptides were not degraded, most probably because of their 4-6 times higher amounts of sugars [7] , which are known to play a protective role against proteolysis. The slight expression of 29.8-kDa IgG band in normal plasma (Table 1 ) may be a result of undiagnosed age related diseases.
Many authors have reported that the majority of the glycosylation changes in RA are related to the degree of glycan branching and the type of substitution of the N-linked glycans with sialic acid and/or fucose [5] . Our previous and present results suggest that the glycosylation proWle of Wbronectin [29] , as well as of IgG and IgA, was quite diVerent in early and advanced RA. The oligosaccharides of synovial IgG and IgA were evidently degraded in early RA and a mixture of their glycoforms appeared in the synovial Xuid. Among them were those which were sialylated and fucosylated as well as those with truncated oligosaccharides, asialylated with exposed galactose, agalactosylated with exposed N-acetylglucosamine, and de-or weakly fucosylated glycoforms (Table 1) . Two fragments of synovial IgG (33.1 and 29.8 kDa) as well as both molecular forms of IgA (65.3 and 58 kDa) were most probably their glycoforms which diVered by the presence of terminal sialic acid, fucoses, and expositions of terminal galactose, or terminal N-acetylglucosamine. For example, the 33.1-kDa IgG fragment (but not 29.8-kDa IgG) and 65.3-kDa IgA (but not 58-kDa IgA) elicited the presence of truncated agalacto-oligosaccharides terminating with N-acetylglucosamine.
The expression of hypo-and agalacto-glycoforms of IgG in blood plasma of RA patients has been shown to be RA speciWc [4] . The association between the presence of glycoform lacking galactose but having exposed N-acetylglucosamine is well accepted RA marker [4, 5] . Its level increase with disease progression and indicate a poor prognosis [4] [5] [6] [7] . Our study indicates that the appearance of the agalacto-glycotope in the 33.1-kDa IgG fragment is exclusively associated with the synovial Xuid (but not with blood plasma) and with the early stage of RA only, whereas its relative amount increases in intact IgA and IgG at the advanced stage. However, the mechanism of agalacto-glycoform production can be complex and seems to be diVerent in early and advanced RA. In early RA the extensive actions of extracellular proteases and glycosidases lead to Fig. 1 The reactivities of synovial IgM, IgA, and IgG with speciWc antibodies and lectins. The synovial immunoglobulin preparations were derived from 1 early and 2 advanced RA stages. The solution containing 2 g of immunoglobulin preparation was subjected to SDS polyacrylamide gel electrophoresis. The synovial immunoglobulin bands were identiWed by Western blot using the respective anti-human antibodies as described in "Materials and methods". Molecular weight standards (S) (see "Materials and methods"). The immunoglobulin molecular weights are the mean of all determinations. The reactivity of the synovial immunoglobulins with lectins separated by Western blot were analysed using the biotinylated lectins SNA, MAA, RCA I, GSL II, AAL, LTA, and UEA 4 the appearance of immunoglobulins without terminal sialic acid and galactose. In contrast, in advanced disease, the reduced activity of endocellular galactosyltransferase [30] leads to the synthesis of immunoglobulin G and A molecules with truncated antennas terminated by galactose and/ or N-acetylglucosamine. The sugar moiety attached to the asparagine-297 residue in the constant domain of IgG is critical for the overall structure and function of the molecule, because removal of this sugar domain leads to the loss of the proinXammatory activity. It suggests that in vivo modulation of antibody glycosylation might be a strategy to interfere with autoimmune processes [31] . Nimmerjahn and Ravetch [32] suggest that high doses of intravenous hypersialylated IgG would be a potent antiinXammatory agent for the use in autoimmune diseases. Authors [32] propose that the Fc-sialylated IgGs engage a unique receptor on macrophages that, in turn, leads to the upregulation of an inhibitory Fc receptor, thereby protecting against autoantibody-mediated pathology.
In conclusion, the analysis of terminal monosaccharides in molecular forms of the IgG and IgA could be included in the list of rheumatological laboratory tests to distinguish the early stage of RA disease from the advanced. Such information is of importance in making decisions about the best medical treatment.
